207 related articles for article (PubMed ID: 10459888)
1. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a routine varicella vaccination program for US children.
Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
4. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
5. Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives.
Hsu HC; Lin RS; Tung TH; Chen TH
Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of routine childhood varicella vaccination in Germany.
Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
[TBL] [Abstract][Full Text] [Related]
8. Instituting a routine varicella vaccination program in Canada: an economic evaluation.
Getsios D; Caro JJ; Caro G; De Wals P; Law BJ; Robert Y; Lance JM
Pediatr Infect Dis J; 2002 Jun; 21(6):542-7. PubMed ID: 12182379
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of varicella vaccine programs for Australia.
Scuffham PA; Lowin AV; Burgess MA
Vaccine; 1999 Oct; 18(5-6):407-15. PubMed ID: 10519929
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of varicella vaccination of healthcare workers.
Chodick G; Ashkenazi S; Livni G; Lerman Y
Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
[TBL] [Abstract][Full Text] [Related]
12. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
[TBL] [Abstract][Full Text] [Related]
15. Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers.
Nettleman MD; Schmid M
Infect Control Hosp Epidemiol; 1997 Jul; 18(7):504-8. PubMed ID: 9247834
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluations of varicella vaccination programmes: a review of the literature.
Thiry N; Beutels P; Van Damme P; Van Doorslaer E
Pharmacoeconomics; 2003; 21(1):13-38. PubMed ID: 12484801
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of varicella vaccination in Spanish adolescents].
Peña-Rey I; Pérez-Farinós N; Cortés-García M; Amela-Heras C
Gac Sanit; 2004; 18(4):287-94. PubMed ID: 15324639
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of varicella vaccination in Canada.
Brisson M; Edmunds WJ
Vaccine; 2002 Jan; 20(7-8):1113-25. PubMed ID: 11803072
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
Smith KJ; Roberts MS
Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
Bonanni P; Boccalini S; Bechini A; Banz K
Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
